Translational Notes: Biotech kibbutz 

 

Table 1. Johnson & Johnson Innovation's deal pipeline. Source: Johnson & Johnson press release

J&J site

Partner

Disease area

Project

Boston Innovation Center

The University of Texas MD Anderson Cancer Research Center

Cancer

Translational oncology research alliance for personalized immunotherapy

 

Intrexon Corp. (NYSE:XON)

Dermatology

Skin and hair care products

 

Scholar Rock LLC

Autoimmune disease; cancer

Transforming growth factor-b1 (TGFB1) activators

California Innovation Center

Assembly Pharmaceuticals Inc.

Infectious disease

Curative therapies for HBV

 

Nodality Inc.

Autoimmune disease

Pharmacogenetics and companion diagnostics for rheumatoid arthritis (RA) and inflammatory bowel disease (IBD)

 

SutroVax Inc.

Infectious disease

Joint venture with Sutro Biopharma Inc. to develop a cell-free platform for vaccine synthesis

London Innovation Center

Bioceros B.V.

Cancer

mAb against an undisclosed immune checkpoint regulator to enhance antitumor immunity

 

TopiVert Ltd.

Inflammation

Kinase modulators for ophthalmic and GI inflammatory diseases